| |
|
| Home | About Us | Services | New Policy | New Patient Information |
| Insurance Networks | Current Studies | Educational Programs | Special Events | FAQ |
|
Current Studies |
|
February 2007 Novartis Pharmaceuticals Corporation is conducting a clinical research study to find out if an oral once-a-day investigational drug called FTY720 is safe and has beneficial effects in people who have Multiple Sclerosis (MS). For more information, please click here. |
|
Multiple Sclerosis Center at Holy Name Hospital 718 Teaneck Road ~Teaneck, New Jersey 07666 USA Telephone: 201-837-0727 ~ Fax: 201-837-8504 ~ Email: info@msccc.org |